The glaucoma therapeutics market is projected to grow from USD 7.7 million in 2025 to USD 11.1 million by 2035, at a CAGR of 3.7%. Eye Drops Glaucoma Therapeutics will dominate with a 48.0% market share, while open-angle glaucoma therapeutics will lead the glaucoma type segment with a 72.0% share.